HeartSciences (HSCS) Total Non-Current Liabilities (2022 - 2026)
HeartSciences (HSCS) reported Total Non-Current Liabilities of $633481.0 for Q1 2026, up 83.17% on a YoY basis from $345844.0 in Q1 2025, and up 156.2% quarter-over-quarter from $247263.0 in Q4 2025.
HeartSciences (HSCS) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
HeartSciences has reported Total Non-Current Liabilities for 5 years, with the latest figure at $633481.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 83.17% year-over-year to $633481.0; the trailing twelve-month figure through Jan 2026 stood at $633481.0 (up 83.17% YoY), and the FY2025 full-year result was $314527.0, down 27.54% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $633481.0, up from $247263.0 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $4.7 million in Q2 2022, with the low at $247263.0 in Q4 2025.
- Historically, Total Non-Current Liabilities has averaged $945389.2 across 5 years, with a median of $518056.0 in 2022.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities tumbled 73.82% — and 2026, when it surged 83.17%.
- HeartSciences' Total Non-Current Liabilities stood at $549227.0 in 2022, then decreased by 11.35% to $486885.0 in 2023, then fell by 5.97% to $457814.0 in 2024, then tumbled by 45.99% to $247263.0 in 2025, then surged by 156.2% to $633481.0 in 2026.
- The last three Total Non-Current Liabilities figures came in at $633481.0 (Q1 2026), $247263.0 (Q4 2025), and $281570.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | 633,481.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 633,481.00 |
| Oct 31, 2025 | 247,263.00 |
| Jul 31, 2025 | 281,570.00 |
| Apr 30, 2025 | 314,527.00 |
| Jan 31, 2025 | 345,844.00 |
| Oct 31, 2024 | 457,814.00 |
| Jul 31, 2024 | 905,743.00 |
| Apr 30, 2024 | 434,045.00 |
| Jan 31, 2024 | 460,859.00 |
| Oct 31, 2023 | 486,885.00 |
| Jul 31, 2023 | 1.22 Mn |
| Apr 30, 2023 | 1.22 Mn |
| Jan 31, 2023 | 1.75 Mn |
| Oct 31, 2022 | 549,227.00 |
| Jul 31, 2022 | 1.14 Mn |
| Apr 30, 2022 | 4.67 Mn |